University of California, San Francisco3d
UCSF Among First in U.S. to Receive New Pulmonary Care Designation
The Bronchiectasis and NTM Association has accepted UC San Francisco (UCSF) into its Bronchiectasis and NTM Care Center Network (CCN), recognizing UCSF’s dedication to providing high-quality medical ...
Live Science on MSN21d
What is double pneumonia? Pope Francis's diagnosis explained.
Pope Francis is being treated in hospital for double pneumonia — but what is this condition, and why might the pope be particularly vulnerable to it?
The Cardiology Advisor11d
In Bronchiectasis, Macrolide Maintenance Therapy Reduces Cardiovascular Events
Macrolide maintenance therapy in patients with bronchiectasis significantly reduces the risk for major adverse cardiovascular events.
EurekAlert!3d
Thirty-three centers join new Bronchiectasis and NTM Care Center Network
The Bronchiectasis and NTM Association has accepted 27 Care Center and six Clinical Associate Center sites in 23 states and the District of Columbia into the new Bronchiectasis and NTM Care Center ...
Pope Francis’ medical condition: What to know about bilateral pneumonia
Following Pope Francis’ diagnosis of bilateral pneumonia, respiratory doctors are speaking about the condition. The Vatican announced the Catholic leader’s diagnosis this week.
pharmaphorum2d
FDA starts review of first bronchiectasis drug candidate
"Brensocatib has the potential to transform the treatment landscape for bronchiectasis and we were pleased to receive the FDA acceptance of our NDA with priority review even earlier than ...
ABC News24d
Pope Francis has pneumonia but remains in 'good spirits,' Vatican says
"The polymicrobial infection, which arose on a picture of bronchiectasis and asthmatic bronchitis, and which required the use of cortisone antibiotic therapy, makes therapeutic treatment more ...
Insmed Announces FDA Not Holding Advisory Committee Meeting for Brensocatib NDA
Insmed Incorporated (NASDAQ: INSM) announced on February 24, 2025 that the U.S. Food and Drug Administration (FDA) does not currently plan to hold an advisory committee meeting to discuss the ...
pharmaphorum1d
LifeArc commits £10m to fund repurposed chronic respiratory infection therapies
Despite significant advances in treatment in recent years ... which ideally have broad potential benefits for people with bronchiectasis and cystic fibrosis. We particularly welcome novel ...
ABC725d
Pope Francis develops bilateral pneumonia, events canceled this week, Vatican says
"The polymicrobial infection, which arose on a picture of bronchiectasis and asthmatic bronchitis, and which required the use of cortisone antibiotic therapy, makes therapeutic treatment more ...